Wisconsin reports first measles death since 1990. TheHill.com article. Pull quote: “Wisconsin ranks among the states with the lowest coverage of measles, mumps and rubella (MMR) vaccinations. According to DPH, 79.8 percent of children had received one or more doses of the MMR vaccine by they time they were 24 months old.”
US measles status to go up for review. TheHill.com article. Pull quote: “And members of the Trump administration have continued to cast doubt on the safety and efficacy of the measles, mumps and rubella vaccine, with President Trump calling the combined shot “quite lethal” from the Oval Office in August.”
The U.S. Has Lost Its Measles-Elimination Status, Data Suggests. NYTimes.com article. Pull quote: “Publicly available data shows that several chains of transmission have continued for more than a year in the United States, according to scientists who analyzed the data at the request of The New York Times.”
Infant Bleeding Rises as Newborn Vitamin K Shots Have Fallen. MedPageToday.com article. Pull quote: “Classical vitamin K deficiency occurs between 2 days and 1 week after birth and leads to umbilical bleeding and bruising. Late vitamin K deficiency occurs between ages 1 week and 6 months and has a 30% to 60% risk of intracranial hemorrhage. Studies have shown that infants without vitamin K shots were 81 times more likely to develop late vitamin K deficiency bleeding.”
Yakima County, Washington, reports 2 more avian flu cases, 1 death. CIDRAP.umn.edu article. Pull quote: “In other avian flu news, for the first time since 2024 Colorado has detected the virus during routine milk tank testing, with officials confirming H5N1 at a Weld County dairy.”
Surging measles cases are forcing doctors to treat conditions they’ve never seen. WashingtonPost.com article. Pull quote: “Scientists at the CDC sought to send an urgent nationwide alert to clinicians about the risks and management of measles during pregnancy as cases increased, but the alert was not approved, The Washington Post previously reported.”
Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy. MedPageToday.com article. Pull quote: "Omalizumab is not a cure for alpha-gal syndrome, nor should it be considered [as] putting these patients into remission. But it could reduce reaction frequency and severity, decrease the need for epinephrine, and then potentially even lessen the fear of unexpected reactions. And that would hopefully translate into meaningful improvement in quality of life for these patients."
